Evidence map›Paper›PMID 28625726›Full record

ArticleJournal of pharmaceutical sciences2017

Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.

Christopher Kuehl, Sharadvi Thati, Bradley Sullivan, Joshua Sestak, Michael Thompson, Teruna Siahaan, Cory Berkland

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  6. Review
  7. Article
  8. Analysis of NAnalytical biochemistry · 2021
    Article
  9. Article
  10. Article
  11. Review
  12. Linking autoantigen properties to mechanisms of immunity.Advanced drug delivery reviews · 2020
    Review
  13. Engineering Immune Tolerance with Biomaterials.Advanced healthcare materials · 2019
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher KuehlDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Sharadvi ThatiDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Bradley SullivanDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Joshua SestakDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Michael ThompsonDepartment of Pathology, Lawrence Memorial Hospital, Lawrence, Kansas 66044.
Teruna SiahaanDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.
Cory BerklandDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047; Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Electronic address: berkland@ku.edu.
University of Kansas · USLawrence General Hospital · US

Funding

TRAINING GRANT IN DYNAMIC ASPECTS OF CHEMICAL BIOLOGYT32GM008545 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI LAMB, AUDREY L · 1994 to 2019
$4.9M
Targeted nanoscale antigen arrays for treating autoimmune diseasesR56AI091996 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI BERKLAND, CORY · 2012 to 2012
$381k
NIAID NIH HHS R56 AI091996NIGMS NIH HHS T32 GM008545
6 · The paper itself

Abstract

Antigen-specific immunotherapy has been used to hyposensitize patients to allergens and offers an enticing approach for attenuating autoimmune diseases. Applying antigen-specific immunotherapy to mucosal surfaces such as the lungs may engage unique immune response pathways to improve efficacy. Pulmonary delivery of soluble antigen arrays (SAgAs) was explored in mice with experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. SAgAs were designed to impede immune response to autoantigen epitopes and are composed of a hyaluronan backbone with peptides PLP

Indexed as

AnimalsAntigensAutoantigensCytokinesEncephalomyelitis, Autoimmune, ExperimentalFemaleHyaluronic AcidImmune ToleranceImmunotherapyInstillation, DrugLungMiceMyelin Proteolipid ProteinPeptide FragmentsAntigensAutoantigensCytokinesHyaluronic AcidMyelin Proteolipid Proteinmyelin proteolipid protein (139-151)Peptide Fragmentsexperimental autoimmune encephalomyelitismacromolecular drug deliverypeptidespulmonary drug deliverypulmonary instillation

Identifiers

PMID28625726
PMCPMC5643236
OpenAlexW2626493217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.